Hirakata, Japan

Junya Okada

This inventor holds 2 USPTO granted patents. Top assignee: Takeda Chemical Industries, Inc.. Active years: 1984-1985.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Junya Okada. Retrieved from https://idiyas.com/inventor/junya-okada

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.4

ph-index = 2

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 1984-1985

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Junya Okada: Innovator in Antibiotic Development

Introduction

Junya Okada is a prominent inventor based in Hirakata, Japan. He has made significant contributions to the field of antibiotic development, particularly focusing on enhancing the efficacy and stability of antibiotic compounds.

Latest Patents

Okada holds 2 patents, with his latest innovations including an inclusion compound of lankacidin-group antibiotic and its use. This compound, which combines lankacidin-group antibiotics with cyclodextrin, demonstrates enhanced water-solubility and stability. It is particularly useful in veterinary medicine for curing swine dysentery. The preparation method involves adding the lankacidin-group antibiotic to an aqueous cyclodextrin solution and stirring it to achieve the desired compound.

Career Highlights

Junya Okada is associated with Takeda Chemical Industries, Inc., a leading company in the pharmaceutical sector. His work focuses on improving antibiotic production and formulation, contributing to advancements in veterinary and human medicine.

Collaborations

Okada collaborates with notable colleagues, including Setsuo Harada and Takashi Suzuki, who share his commitment to innovation in antibiotic research.

Conclusion

Junya Okada's work in antibiotic development showcases his dedication to improving healthcare solutions. His innovative patents and collaborations highlight his significant role in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…